Towards a molecular understanding of polycythemia rubra vera

European Journal of Biochemistry

Volumn 267, Issue 12, 2000, Pages 3395-3401

  Pahl, Heike L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Erythrocytosis; Myeloproliferative disorders; Polycythemia; PV

Indexed keywords

DISEASE CLASSIFICATION; ERYTHROCYTOSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW;

BCL-X PROTEIN; ERYTHROPOIETIN; GROWTH SUBSTANCES; HUMANS; ISOANTIGENS; MEMBRANE GLYCOPROTEINS; MYELOPROLIFERATIVE DISORDERS; NEOPLASM PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; POLYCYTHEMIA VERA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOKINE; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, THROMBOPOIETIN; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 0033930839     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01352.x     Document Type: Review

References (91)

1. 1. Dameshek, W. (1951) Some speculations on the myeloproliferative syndromes. Blood 6, 372-375.
2. 2. Tefferi, A. (1999) Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia. Sem. Hematol. 36, 3-8.
3. 3. Michiels, J.J., Kutti, J., Stark, P., Bazzan, M., Gugliotta, L., Marchioli, R., Griesshammer, M., van Genderen, P.J., Briere, J., Kiladjian, J.J., Barbui, T., Finazzi, G., Berlin, N.I., Pearson, T.C., Green, A.C., Fruchtmann, S.M., Silver, R.T., Hansmann, E., Wehmeier, A., Lengfelder, E., Landolfi, R., Kvasnicka, H.M., Hasselbalch, H., Cervantes, F., Thiele, J. et al. (1999) Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Netherlands J. Med. 54, 46-62.
4. 4. Adamson, J.W., Fialkow, P.J., Murphy, S.F., P.J. & Steinmann, B.A. (1976) Polycythemia vera: stem-cell and probable clonal origin of the disease. New Engl. J. Med. 295, 913-916.
5. 5. Jacobson, R.J., Salo, A. & Fialkow, P.J. (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood. 51, 189-194.
6. 6. Fialkow, P.J.J.J.R., Singer, J.W., Sacher, R.A.W., M.R. & Neefe, J.R. (1980) Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell. Blood. 56, 70-73.
7. 7. Fialkow, P.J., Faguet, G.B., Jacobson, R.J., Vaidya, K. & Murphy, S. (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood. 58, 916-919.
8. 8. Bilgrami, S. & Greenberg, B.R. (1995) Polycythemia rubra vera. Sem. Onc. 22, 307-326.
9. 9. Policitemia, G.I.S. (1995) Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann. Intern. Med. 123, 656-664.
10. 10. Sterkers, Y., Preudhomme, C., Lai, J.L., Demory, J.L., Caulier, M.T., Wattel, E., Bordessoule, D., Bauters, F. & Fenaux, P. (1998) Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood. 91, 616-622.
11. 11. Fenaux, P., Simon, M., Caulier, M.T., Lai, J.L., Goudemand, J. & Bauters, F. (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer. 66, 549-556.
12. 12. Faderl, S., Talpaz, M., Estrov, Z. & Kantarjian, H.M. (1999) Chronic myelogenous leukemia: biology and therapy. Ann. Int. Med. 131, 207-219.
13. 13. Landaw, S.A. (1986) Acute leukemia in polycythemia vera, Sem. Hematol. 23, 156-165.
14. 14. Osarogiagbon, U.R. & McGlave, P.B. (1999) Chronic myelogenous leukemia. Curr. Opin. Hematol. 6, 241-246.
15. 15. Shih, L.-Y. & Lee, C.-T. (1994) Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 83, 744-748.
16. 16. Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.M., Witte, O.N. & Baltimore, D. (1986) The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233, 212-214.
17. 17. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R. & Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 36, 93-99.
18. 18. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550-554.
19. 19. Daley, G.Q., Van Etten, R.A. & Baltimore, D. (1991) Blast crisis in a murine model of chronic myelogenous leukemia. Proc. Natl Acad. Sci. USA 88, 11335-11338.
20. 20. Daley, G.Q., Van Etten, R.A. & Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824-830.
21. 21. Wells, S.J., Phillips, C.N., Winton, E.F. & Farhi, D.C. (1996) Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia. Am. J. Clin. Pathol. 105, 756-760.
22. 22. Bentz, M., Cabot, G., Moos, M., Speicher, M.R., Ganser, A., Lichter, P. & Dohner, H. (1994) Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood. 83, 1922-1928.
23. 23. Prchal, J.F. & Prchal, J.T. (1999) Molecular basis for polycythemia. Curr. Opin. Hematol. 6, 100-109.
24. 24. de Klerk, G., Rosengarten, P.C., Vet, R.J. & Goudsmit, R. (1981) Serum erythropoietin (ESF) titers in polycythemia. Blood. 58, 1171-1174.
25. 25. Erslev, A.J., Caro, J., Kansu, E., Miller, O. & Cobbs, E. (1979) Plasma erythropoietin in polycythemia. Am. J. Med. 66, 243-247.
26. 26. Ellis, J.T. & Peterson, P. (1979) The bone marrow in polycythemia vera. Pathol Annu. 14, 383-403.
27. 27. Kreipe, H., Radzun, H.J., Bartels, H.V., Heyden, H.-W., Löffler, H. & Parwaresch, M.R. (1990) Detection of clonality and stem cell mutations in chronic myelopoliferative disorders. Verh. Dtsch. Ges. Path. 74, 49-64.
28. 28. Kreipe, H., Felgner, J., Jaquet, K., Heidorn, K., Radzun, H.J. & Parwaresch, R. (1992) DNA analysis to aid in the diagnosis of chronic myeloproliferative disorders. Am. J. Clin. Pathol. 98, 46-54.
29. 29. Tsukamoto, N., Monta, K., Maehara, T., Okamoto, K., Sakai, H., Karasawa, M., Naruse, T. & Omine, M. (1994) Clonality in chronic myeloproliferalive disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. Brit. J. Haematol. 86, 253-258.
30. 30. Gilliland, D.G., Blanchard, K.L., Levy, J., Perrin, S. & Bunn, H.F. (1991) Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc. Natl Acad. Sci. USA 88, 6848-6852.
31. 31. Anger, B., Janssen, J.W., Schrezenmeier, H., Hehlmann, R., Heimpel, H. & Bartram, C.R. (1990) Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 4, 258-261.
32. 32. Hinshelwood, S., Bench, A.J. & Green, A.R. (1997) Pathogenesis of polycythaemia vera. Blood Rev. 11, 224-232.
33. 33. Raskind, W.H., Jacobson, R., Murphy, S., Adamson, J.W. & Fialkow, P.J. (1985) Evidence for the involvement of B lymphoid cels in polycythemia vera and essential thrombocythemia. J. Clin. Invest. 75, 1388-1390.
34. 34. Rege-Cambrin, G., Mecucci, C., Tricot, G., Michaux, J.L., Louwagie, A., Van Hove, W., Francart, H. & Van den Berghe, H. (1987) A chromosomal profile of polycythemia vera. Cancer Genet. Cytogenet. 25, 233-245.
35. 35. Mertens, F., Johansson, B., Heim, S., Kristoffersson, U. & Mitelman, F. (1991) Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia 5, 214-220.
36. 36. Dewald, G.W. & Wright, P.I. (1995) Chromosome abnormalities in the myeloproliferative disorders. Sem. Oncol. 22, 341-354.
37. 37. Najfeld, V. (1997) FISHing among myeloproliferative disorders. Sem. Hematol. 34, 55-63.
38. 38. Bench, A.J., Aldred, M.A., Humphray, S.J., Champion, K.M., Gilbert, J.G., Asimakopoulos, F.A., Deloukas, P., Gwilliam, R., Bentley, D.R. & Green, A.R. (1998) A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genomics 49, 351-362.
39. 39. Asimakopoulos, F.A., Gilbert, J.G., Aldred, M.A., Pearson, T.C. & Green, A.R. (1996) Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera. Blood 88, 2690-2698.
40. 40. Kennedy, E.P. & Hamilton, S.R. (1998) Genetics of colorectal cancer. Sem. Surg. Oncol. 15, 126-130.
41. 41. Ilyas, M., Straub, J., Tomlinson, I.P. & Bodmer, W.F. (1999) Genetic pathways in colorectal and other cancers. Eur. J. Cancer 35, 335-351.
42. 42. Prchal, J.F. & Axelrad, A.A. (1974) Bone-marrow responses in polycythemia vera. N. Engl. J. Med. 290, 1382.
43. 43. Eaves, C.J. & Eaves, A.C. (1978) Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood. 52, 1196-1210.
44. 44. Shin, L.Y., Lee, C.T., See, L.C., Ou, Y.C., Dunn, P., Wang, P.N., Kuo, M.C. & Wu, J.H. (1998) In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia. Eur. J. Clin. Invest. 28, 569-576.
45. 45. Biljanovic-Paunovic, L., Ruvidic, R. & Pavlovic-Kentera, V. (1990) Endogenous BFU-E in peripheral blood in diagnosis of polycythemia vera. Eur. J. Haematol. 45, 262-266.
46. 46. Lutton, J.D. & Levere, R.D. (1979) Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera. Acta Haematologica 62, 94-99.
47. 47. Lacombe, C., Casadevall, N. & Varet, B. (1980) Polycythaemia vera: in vitro studies of circulating erythroid progenitors. Brit. J. Haematol. 44, 189-199.
48. 48. Beckman, B.S., Anderson, W.F., Beitran, G.S., Beckman, E.N. & Fisher, J.W. (1983) Diagnostic use of CFU-E formation from peripheral blood in polycythemia vera. Am. J. Clin. Pathol. 79, 496-499.
49. 49. Westwood, N.B. & Pearson, T.C. (1996) Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leukemia Lymphoma 22, 95-103.
50. 50. Fisher, M.J., Prchal, J.F., Prchal, J.T. & D'Andrea, A.D. (1994) Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera. Blood 84, 1982-1991.
51. 51. Correa, P.N., Eskinazi, D. & Axelrad, A.A. (1994) Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-I in vitro: studies in an improved serum-free medium. Blood 83, 99-112.
52. 52. Mirza, A.M., Correa, P.N. & Axelrad, A.A. (1995) Increased basal and induced tyrosine phosphorylation of the insulin-like frowth factor 1 receptor β subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 86, 877-882.
53. 53. Mirza, A.M., Ezzat, S. & Axelrad, A.A. (1997) Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro. Blood 89, 1862-1869.
54. 54. Dai, C.-H., Krantz, S.B., Means, R.T., Horn, S.T. & Gilbert, H.S. (1991) Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. J. Clin. Invest. 87, 391-396.
55. 55. Dai, C.H., Krantz, S.B. & Dessypris, E.N. (1992) Polycythemia vera II: hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin 3 and granulocyte-macrophage colony-stimulating factor. Blood 80, 891-899.
56. 56. Dai, C.H., Krantz, S.B., Green, W.F. & Gilbert, H.S. (1994) Polycythemia vera III: Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br. J. Haematol. 86, 12-21.
57. 57. Martin, J.M., Gandhi, K., Jackson, W.R. & Dessypris, E.N. (1996) Hypersensitivity of polycythemia vera megakaryocytic progenitors to thrombopoetin. Blood 88, 97a.
58. 58. Le Couedic, J.P., Mitjavila, M.T., Villeval, J.L., Feger, F., Gobert, S., Mayeux, P., Casadevall, N. & Vainchenker, W. (1996) Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood. 87, 1502-1511.
59. 59. Hess, G., Rose, P., Gamm, H., Papadileris, S., Huher, C. & Seliger, B. (1994) Molecular analysis of the erythropoietin receptor system in patients with polycythemia vera. Br. J. Hematol. 88, 794-802.
60. 60. Emanuel, P.D., Eaves, C.J., Broudy, V.C., Papayannopoulou, T., Moorre, M.R., D'Andrea, A.D., Prchal, J.F., Eaves, A.C. & Prchal, J.T. (1992) Familial and congenital Polycythemia in three unrelated families. Blood 79, 3019-3030.
61. 61. Nakamura, Y., Komatsu, N. & Nakauchi, H. (1992) A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257, 1138-1141.
62. 62. Chiba, S., Takahashi, T., Takeshita, K., Minowada, J., Yazaki, Y., Ruddle, F.H. & Hirai, H. (1997) Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood 90, 97-104.
63. 63. Klingmüller, U., Lorenz, U., Cantley, L.C., Neel, B.G. & Lodish, H.F. (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729-738.
64. 64. Yi, T., Zhang, J., Miura, O. & Ihle, J.N. (1995) Hematopoetic cell phosphatase associates with reythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood 85, 87-95.
65. 65. Kozlowski, M., Mlinaric-Rascan, I., Feng, G.-S., Shen, R., Pawson, T. & Siminovitch, K.A. (1993) Expression and catalytic acitivity of the tyrosine phosphatase PTP1c is severely impaired in motheated and viable motheaten mice. J. Exp. Med. 178, 2157-2163.
66. 66. Shultz, L.D., Schweitzer, P.A., Rajan, T.V., Yi, T., Ihle, J.N., Matthews, R.J., Thomas, M.L. & Beier, D.R. (1993) Mutations at the murine motheaten locus are within the hematopoetic cell protein-tyrosine phosphatase (hcph) gene. Cell 73, 1445-1454.
67. v). Exp. Hematol. 17, 81-87.
68. 68. Asimakopoulos, F.A., Hinshelwood, S., Gilbert, J.G., Delibrias, C.C., Gottgens, B., Fearon, D.T. & Green, A.R. (1997) The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera. Oncogene. 14, 1215-1222.
69. 69. Andersson, P., LeBlanc, K., Eriksson, B.A. & Samuelsson, J. (1997) No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythaemia vera. Eur. J. Haematol. 59, 310-317.
70. 70. Ihle, J.N., Witthuhn, B.A., Quelle, F.W., Yamamoto, K. & Silvennoinen, O. (1995) Signaling through the hematopoietic cytokine receptors. Ann. Rev. Immunol. 13, 369-398.
71. 71. Liu, K.D., Gaffen, S.L. & Goldsmith, M.A. (1998) JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 10, 271-278.
72. 72. Heim, M.H. (1999) The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J. Receptor Signal Transduction Res. 19, 75-120.
73. 73. Röder, S. & Pahl, H.L. (1999) STAT3 is constitutively active in some patients with polycythemia vera. Blood 94, 113a.
74. 74. Moliterno, A.R., Hankins, D. & Spivak, J.L. (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N. Engl. J. Med. 338, 572-580.
75. 75. Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y. & Kanakura, Y. (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 90, 4031-4038.
76. 76. Harrison, C.N., Gale, R.E., Pezella, F., Mire-Sluis, A., Machin, S.J. & Linch, D.C. (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Br. J. Haematol. 107, 139-147.
77. 77. Silva, M., Richard, C., Benito, A., Sanz, C., Olalla, I. & Fernandez-Luna, J.L. (1998) Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N. Engl. J. Med. 338, 564-571.
78. 78. Muta, K. & Krantz, S.B. (1993) Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J. Cell. Physiol. 156, 264-271.
79. 79. Lui, Q., Schacher, D., Hurth, C., Freund, G.C., Santzer, R. & Kelley, K.W. (1997) Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-1 rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J. Immunol. 159, 829-837.
80. 80. Minshall, C., Arkins, S., Straza, J., Conners, J., Dantzer, R., Freund, G.G. & Kelley, K.W. (1997) IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J. Immunol. 159, 1225-1232.
81. 81. Streuli, M. (1996) Protein tyrosine phosphatases in signaling. Curr. Opin. Cell Biology. 8, 182-188.
82. 82. Dai, C.-H., Krantz, S.B. & Sawyer, S.T. (1996) Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythrroid cells: a possible defect of phosphatase activity in polycythemia vera. Blood. 88, 145a.
83. 83. Sui, X., Krantz, S.B. & Zhao, Z. (1997) Identification of increased protein tyrosine phosphatase activity in polycythemia vėra erythroid progenitor cells. Blood 90, 651-657.
84. 84. Temerinac, S., Klippel, S., Strunck, E., Röder, S., Lübbert, M., Lange, W., Azemar, M., Meinhardt, G., Schaefer, H.E. & Pahl, H.L. (2000) Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 95, 2569-2576.
85. 85. Stefanova, I., Horejsi, V., Ansotegui, I.J., Knapp, W. & Stockinger, H. (1991) GPI-anchored cell surface molecules complexed to protein tyrosine kinases. Science. 254, 1016-1019.
86. 86. Konakova, M., Hucho, F. & Schleuning, W.-D. (1998) Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur. J. Biochem. 253, 421 -429.
87. 87. Dumler, I., Weis, A., Mayboroda, O.A., Maasch, C., Jerke, U., Haller, H. & Gulba, D.C. (1998) The Jak/Stat Pathway and urokinase receptor signalling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273, 315-321.
88. 88. Bohuslav, J., Horejsi, V., Hansmann, C., Stöckl, J., Weidle, U.H., Majdic, O., Bartke, I., Knapp, W. & Stockinger, H. (1995) Urokinase plasminogen activator receptor β2-integrins, and src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181, 1381-1390.
89. 89. Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P.C. & Binder, B.R. (1997) Urokinase receptor is associated with the components of the JAK/STAT1 signalling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272, 28563-28567.
90. 90. Kim, K.-M., Adachi, T., Nielsen, P.J., Terashima, M., Lamers, M.C., Köhler, G. & Reth, M. (1994) Two new membrane proteins preferentially associated with membrane immunoglobulin D. EMBO J. 13, 3793-3800.
91. 91. Druker, B.J., Talpaz, M., Resta, D., Peng, B., Buchdunger, E., Ford, J. & Sawyers, C.L. (1999) Clinical efficacy and safety of an abl specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia. Blood 94, 368a.